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Introduction
Antimicrobial peptides (AMPs) form a part of the innate 
immune system across eukaryotic organisms and have 
potent therapeutic activity against a wide spectrum of bac-
teria and fungi (Li et al. 2012; Brandenburg et al. 2012; 
Dennison et al. 2005). However, the mechanism of anti-
microbial action of these peptides has yet to be fully elu-
cidated and remains the subject of continuous research 
(Phoenix et al. 2013; Fox 2013; Wimley and Hristova 2011; 
Yeaman and Yount 2003). It is generally accepted that the 
ability of AMPs to kill microorganisms depends upon their 
ability to target the membranes of these organisms (Huang 
and Huang 2010; Strömstedt et al. 2010). AMPs are usu-
ally short molecules of up to 50 amino acid residues and a 
number have been shown to penetrate the membrane in an 
oblique orientation between 30 and 60◦. Therefore, the role 
of the peptide terminus may be crucial in the penetration 
behaviour (Dennison and Phoenix 2011b; Dennison et al. 
2012a). For instance, it was shown that the change in the 
C-terminal of the AMPs can stabilise the secondary struc-
ture and enhance the affinity of the peptide towards the 
membrane (Cao et al. 2005; Ali et al. 2001; Dennison et al. 
2009a, 2012a; Dennison and Phoenix 2011b).
For a number of these peptides, post-translational 
modifications are also essential for their antimicrobial 
activity and the most common of these structural modifi-
cations is carboxyamidation (Sforca et al. 2004; Shalev 
et al. 2002; Dennison and Phoenix 2011b, b). Recently, 
studies by Dennison et al. have shown that aurein 2.5 
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(GLFDIVKKVVGAFGSL-CONH2) has greater antimi-
crobial potency against Klebsiella pneumonia than its car-
boxylated C-terminal analogue (GLFDIVKKVVGAFGSL-
COOH) (Dennison et al. 2012a).
Previous research has demonstrated that the peptide 
structure is crucial in the binding to target membranes. It 
has been proposed that the key driver for increased effi-
cacy by amidation is due to enhanced helix stability at the 
membrane interface, which supports the observation that 
amidated peptide modelin-5-CONH2 exhibited a higher 
level of helicity in comparison to modelin-5-COOH (Den-
nison and Phoenix 2011b). In support of this observation 
other researchers such as Sforca et al. suggested that the 
reduced antibacterial activity of non-amidated peptides is 
caused not only by the decreased positive surface charge 
but also by the structural perturbation of the amphiphilic 
α-helix, which affects its ability to disturb the cell mem-
brane (Sforca et al. 2004). However, other researchers have 
shown that the N-terminal pGlu and amidated C-terminal 
do not significantly influence the β-hairpin amphiphilic 
structure of Gomesin but are critical for Gomesin’s antimi-
crobial activity (Machado et al. 2012).
Despite the large body of experimental work on the role 
of amidation in the membrane interaction of AMPs using a 
wide range of techniques, such as Nuclear magnetic reso-
nance (NMR) (Haney and Vogel 2009), circular dichroism 
(CD) (Greenfield 1999), fluorescence (Bocchinfuso et al. 
2011), and lipid monolayer analysis (Dennison et al. 2010), 
detailed understanding of the mechanism underpinning 
this role is not yet fully understood. In response, molecular 
dynamics (MD) provide detailed information at the molec-
ular level into many biological systems, giving an insight 
into the mechanism of interaction of amidated AMPs with 
the membrane (Cheng et al. 2011; Chen et al. 2011).
For example, Wang et al. (2012) used MD simulations 
to show that in the presence of a mixed 1-palmitoyl,2-
oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) lipid 
bilayer (1:2), the C-terminus amidated CM15 peptide inter-
acted more strongly with the bilayer than the zwitterionic 
POPC. Dennison and Phoenix (2011b) proposed that the 
mechanism for amidated peptide isoforms to interact with 
membranes may be similar to the mechanism for melittin 
pore formation proposed by van den Bogaart et al. (2008). 
This mechanism shows that the initial binding of peptide 
to the membrane competes with peptide insertion and the 
ability of the peptide to form pores. Irudyam et al. used 
a coarse-grained and atomistic MD approach to investi-
gate the binding and reorientation of melittin to the POPC 
bilayer (Irudayam and Berkowitz 2012). These authors sug-
gested that the stabilisation of the helix at the membrane 
interface increases the concentration of melittin bound to 
the membrane, enabling stable pore formation and hence 
the N-terminus of the peptide to reorientate. Researchers 
have shown that stabilising the helix at the membrane inter-
face increases the local peptide concentration, which leads 
to pore formation, or carpeting of the outer leaflet, thereby 
causing bilayer disruption. In support of this suggestion 
Dos Santos Cabrera et al. (2008) undertook MD analysis 
on amidated and non-amidated decapeptide anoplin (ANP) 
in 2,2,2-trifluoroethanol (TFE)/water mixtures. The latter 
studies provided detailed MD information on the stability 
of the peptide isoforms, supporting previous findings that 
the amidated peptide had a more stable α-helical confor-
mation compared to the non-amidated isoforms (Dos San-
tos Cabrera et al. 2008).
Although MD has been used to gain insight into pep-
tide/membrane interactions, an accurate, full atomistic 
MD investigation of the role played by amidated and non-
amidated peptide is lacking. In the present work, ana-
logues of aurein AMPs isolated from Australian Southern 
Bell frogs, Litoria aurea, were used to investigate the role 
of amidation in the mechanism of membrane interaction 
(Cheng et al. 2009). These peptides show activity against a 
broad range of micro-organisms (Apponyi et al. 2004) and 
tumour activity (Rozek et al. 2000). In this study, aurein 
2.6 and 3.1 are used to investigate the role of amidation in 
the mechanism of membrane action with two model lipid 
bilayers, 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC) and 1,2-dimyristoyl-sn-glycero-3-phosphoserine 
(DMPS), which mimic the mammalian cell membrane. 
Generally, phosphatidylserine (PS) is found primarily in 
the inner leaflet while phosphatidylcholine (PC) is found in 
the outer leaflet. Here, MD and CD spectroscopy were used 
to investigate the membrane interactions of aurein peptides 
and these data were compared to corresponding analyses 
on C-terminally non-aminated isoforms of the peptide.
Methods and materials
Materials
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) 
and 1,2-dimyristoyl-sn-glycero-3-phosphoserine (DMPS) 
were obtained from Avanti Polar Lipids (Alabaster, AL, 
USA) and used without further modification. The pep-
tide analogues of aurein peptides—aurein 2.6-COOH 
(GLFDIAKKVIGVIGSL-COOH), aurein 2.6-CONH2 
(GLFDIAKKVIGVIGSL-CONH2), aurein 3.1-COOH 
(GLFDIVKKIAGHIAGSI-COOH), and aurein 3.1-CONH2 
(GLFDIVKKIAGHIAGSI-CONH2)—were synthesised by 
SevernBiotech (UK) by solid-state synthesis and purified 
by HPLC to purity greater than >95 %. 2,2,2-Trifluoroetha-
nol (TFE) and all other solvents and reagents were supplied 
by Fisher Scientific UK.
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Circular dichroism measurements
The CD spectrum was recorded on a J-815 spectropola-
rimeter (JASCO, UK) equipped with a Peltier temperature 
control unit maintained at 30 ◦C as previously described 
(Dennison et al. 2013). All CD experiments were under-
taken using a 10-mm path-length cell over a 260–180-nm 
wavelength range at a scan speed of 50 nm/min, 1 nm 
band width, and a data pitch of 0.5 nm. For all spectra 
acquired, ten scans per sample were performed and aver-
aged, and the baseline acquired in the absence of pep-
tide was subtracted. Samples were prepared by dissolv-
ing each peptide in phosphate-buffered saline (PBS, pH 
7.5) and 100 % TFE to give a final peptide concentration 
of 0.01 mg ml−1 . CD structural analysis was also per-
formed with aurein 2.6 and aurein 3.1 peptide isoforms 
in the presence of lipid. To obtain small lamellar vesicles 
(SUVs), a predetermined amount of dried (5 mg ml−1) 
DMPC and DMPS was dissolved in chloroform, evapo-
rated under a nitrogen stream, and placed under a vacuum 
overnight. The lipid film was then rehydrated using PBS 
(pH 7.5) and sonicated for 1 h or until the solution was 
no longer turbid. Liposomes were then extruded 11 times 
through a 0.1-µm polycarbonate filter using an Avanti 
polar lipid mini-extruder apparatus. Peptide/lipid sam-
ples were prepared by adding stock peptide solution to a 
measured volume of lipid suspension to obtain the desired 
peptide:lipid molar ratio (1:100) before thorough mix-
ing. For secondary structure estimation, the percentage 
α-helical content of the CD spectra was then estimated 
using the CDSSTR, CONTIN, and SELCON3 algorithm 
(protein reference set 3,4,7, SPI75 and smo 180) on the 
DichroWeb server (Whitmore and Wallace 2004, 2008; 
Whitmore et al. 2010).
Computational method
The amidation effects of three aurein 2.6 and aurein 3.1 
in different environments including water, TFE, DMPC, 
and DMPS were simulated by MD simulations. The 
mechanism of interaction between each aurein analogue 
and 0.1 mol/l aqueous solution, TFE, DMPC, or DMPS 
was examined. The aurein peptides were assembled as 
a canonical α-helix using AMBER tools 1.5. All simu-
lations were performed with the GROMACS software 
package (Van Der Spoel et al. 2005; Hess et al. 2008; 
Mura et al. 2013; Dennison et al. 2013). The GRO-
MOS53a6 force field was used to model the peptides in 
the presence of TFE (Fioroni et al. 2000; Malde et al. 
2011; Mura et al. 2013; Dennison et al. 2013). Water was 
represented by a simple point charge (SPC) (Van Der 
Spoel et al. 1998). The force field for DMPS and DMPC 
were based on GROMOS53a6 force fields taken from the 
literature: Poger and Mark (2010), Nesterenko and Erma-
kov (2013), Malde et al. (2011), and Kandt et al. (2010). 
All structures were equilibrated at room temperature in 
water (NVT and NPT simulations). Two configurations 
were considered: in one case the peptides were outside 
the lipid bilayer system with the helical axis parallel to 
the lipid bilayer surface while in the second case the pep-
tides were inserted into the lipid bilayer with the helical 
axis parallel to the Z direction and relaxed in accordance 
with the protocol in Kandt et al. (2010). In the first case 
the peptides were placed at a distance of 3 nm from the 
top leaflet of the lipid bilayer with its axis perpendicu-
lar to the lipid-water interface (Mura et al. 2013). The 
simulations were performed by solvating the box with the 
peptides or the peptide/lipid, and counter ions Na+ and 
CL− were added to neutralise the systems (see Table 2). 
Each system was equilibrated at 310 K in the sequence 
minimisation, NVT, and NPT simulations. An equilibra-
tion run of 2-ns NVT and 2-ns NPT was undertaken for 
all systems with the position of the peptide restrained 
using harmonic restraints with a constant force of 1.0 
kJ−1 nm−2 per atom (Tieleman 2012; Chen et al. 2011; 
Kukol 2009; Mura et al. 2013). The cutoff for both van 
der Waals and Coulombic interactions is 1.2 nm. The par-
ticle mesh Ewald (PME) method was used in all simu-
lations. The temperature was coupled for single groups 
with a constant time for the coupling of 0.1 ps to 310 K 
using the Berendsen thermostat. A semi-isotropic Ber-
endsen barostat was also used with a coupling time of 
2.0 ps (Piggot et al. 2011; Kukol 2009; Mura et al. 2013; 
Dennison et al. 2013). Simulations were undertaken at 
constant temperature, pressure, and number of molecules. 
All simulations were undertaken with constraints on all 
bond lengths using the LINCS algorithm (Hess et al. 
1997). Then 200-ns simulations were performed in the 
NPT ensemble using periodic boundary conditions. The 
components of each system are shown in Table 1 (Den-
nison et al. 2013).
We calculated the hydrogen bonds using the post-pro-
cessing ghbond option in GROMACS. The cutoff angle is 
30◦ and cutoff distance 3.5 Å.
Results
Amidation effects on the structure and stability 
of aurein peptides
Amidation of the C-terminus of peptides may disturb the 
intramolecular hydrogen bonds (HBs) in peptides and in 
the intermolecular ones between peptides and the solvent 
molecules. Thus the driving force to form α-helical or β
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-sheet structures can be varied. Previous studies have pro-
posed that the secondary structures of AMPs are likely 
to be affected by amidation of the C-terminus (Dennison 
et al. 2013). Our investigation focuses on the peptide mem-
brane interaction using experimental and computational 
techniques.
Table 1  Details of the MD 
simulations for aureins 2.6 (A 
2.6) and aureins 3.1 (A 3.1)
Box size (nm) Water Ions
 Water environment
 CONH2
  A 2.6 8.0 × 8.0 × 8.0 16,815 31Na+:34Cl−
  A 3.1 8.0 × 8.0 × 8.0 16,808 31Na+:34Cl−
 COOH
  A 2.6 7.0 × 7.0 × 7.0 11,117 21Na+:24Cl−
  A 3.1 6.8 × 6.8 × 6.8 10,180 19Na+:22Cl−
Box  size (nm) TFE Ions
TFE environment
 CONH2
  A 2.6 6.8 × 6.8 × 6.8 2470 21Na+:24Cl−
  A 3.1 6.8 × 6.8 × 6.8 2503 2Na+:5Cl−
 COOH
  A 2.6 7.7 × 6.8 × 6.8 1390 11Na+:14Cl−
  A 3.1 7.7 × 6.8 × 6.8 1368 11Na+:14Cl−
Box  size (nm) Water Ions
DMPC 128 lipids peptide outside
  CONH2
  A 2.6 6.5 × 6.5 × 9.1 7478 3Cl−
  A 3.1 6.3 × 6.3 × 9.3 7388 3Cl−
 COOH
  A 2.6 6.3 × 6.3 × 9.3 7413 3Cl−
  A 3.1 6.4 × 6.4 × 9.1 7416 3Cl-
DMPC 127 lipids peptide inside
 CONH2
  A 2.6 6.5 × 6.5 × 9.5 7981 3Na+:6Cl−
  A 3.1 6.3 × 6.3 × 7.1 4601 2Na+:5Cl−
 COOH
  A 2.6 6.4 × 6.4 × 9.0 7138 3Na+:6Cl−
  A3.1 6.4 × 6.4 × 7.0 4602 2Na+:5Cl−
DMPS 128 lipids peptide outside
 CONH2
  A 2.6 5.5 × 5.5 × 12.6 8073 128Na+:3Cl−
  A 3.1 5.5 × 5.5 × 12.4 8066 128Na+:3Cl−
 COOH
  A 2.6 5.5 × 5.5 × 12.8 8083 128Na+:3Cl−
  A 3.1 5.5 × 5.5 × 12.3 8065 128Na+:3Cl−
DMPS peptide inside
 CONH2
  A 2.6 5.7 × 5.7 × 8.3 4642 125Na+:2Cl−
  A 3.1 5.7 × 5.7 × 9.8 6346 128Na+:3Cl−
 COOH
  A 2.6 5.7 × 5.7 × 8.7 5076 125Na+:2Cl−
  A 3.1 5.8 × 5.8 × 9.3 6630 127Na+:3Cl−
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Table 2  The CD and 
MD secondary structure 
of the aureins in different 
environments
 A2.6-COOH A2.6-CONH2 
 CD MD CD MD 
Water - 29±5% 9±7% - - 
TFE 75±2% 50±5% 71±1% 59±5% 
Out DMPC 49±4% 28±4% 12±5% 56±1% 31±2% 11±3% In DMPC 58±2% 39±3% 
Out DMPS 48.0±0.7% 28±2% 56±2% 32±2% In DMPS 70±2% 68±3% 
 
 A3.1-COOH A3.1-CONH2 
 CD MD CD MD 
Water - 2±3% 15±7% - - 
TFE 63.0±0.5% 22±7% 69±0.6% 28±4% 
Out DMPC 42.0±0.7% 30±2% 7±3% 38±1% 16±2% 6±5% In DMPC 82±2% 49±3% 
Out DMPS 40.0±0.2% 12±2% 7±4% 61±2% 34±2% 11±4% In DMPS 54±2% 62±3% 
The secondary structure in MD 
has been averaged over the 
last 50 ns of the simulations. 
Blue boxes ratio of α-helix; red 
boxes ratio of β-sheet; the dash 
represents 100 % random coil
Fig. 1  CD spectra of aurein 3.1-CONH2 (black), aurein 3.1-COOH (grey), and aurein 2.6-CONH2 (dotted black) aurein 2.6-COOH (dotted 
grey) in the presence of aqueous solution (a), TFE (b), DMPC (c), and DMPS (d)
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Secondary structure analysis using CD
In order to investigate the secondary structures of aurein 
2.6 and aurein 3.1 isoforms in membrane mimetic environ-
ments, CD spectra were measured in PBS (pH 7.4), TFE, 
DMPC, and DMPS membranes (Fig. 1). Aurein 2.6 and 
3.1 isoforms in PBS displayed spectral characteristics of a 
random coil structure (Fig. 1a). However, in a membrane 
environment each peptide studied adopted an α-helical con-
formation displaying characteristic minima at 221–222 and 
209–210 nm and a maximum at about 190 nm (Fig. 1b, c). 
The spectrum of aurein 2.6-COOH showed enhanced lev-
els of helicity (75 %) in the presence of TFE compared to 
that of aurein 2.6-CONH2 (71 %). In contrast, the spectrum 
of aurein 3.1-CONH2 (69 %) showed an enhanced level of 
helicity compared to aurein 3.1-COOH (62 %), suggesting 
that amidation increased the propensity for the amidated 
peptide to form an α-helical structure. Since it is widely 
accepted that cationic AMPs adopt an enhanced helical 
structure at a membrane-lipid interface (Dennison et al. 
2013), CD experiments were undertaken in the presence 
of DMPC and DMPS lipid vesicles (Fig. 1c, d). CD spec-
troscopy spectral analysis in the presence of DMPC vesi-
cles induced 56 % helical content in aurein 2.6-CONH2 and 
49 % helicity in the case of aurein 2.6-COOH, showing that 
amidation enhanced the helical content (Fig. 1c). However, 
for aurein 3.1 isoforms in the presence of DMPC vesicles 
CD analysis showed that both peptides were circa 40 % 
helical (Table 2), indicating that amidation had no effect 
on these membranes. In contrast, in the presence of anionic 
DMPS vesicles (Fig. 1d), the spectrum of both amidated 
and non-amidated aureins showed a significant increase in 
helical content with aurein 2.6-CONH2 exhibiting a higher 
helical content (56 %) compared to aurein 2.6-COOH 
(48 %). Similarly, in the presence of DMPS vesicles aurein 
3.1-CONH2 exhibited a higher helical content (63 %) com-
pared to aurein 3.1-COOH (43 %).
Secondary structure analysis using MD
The secondary structure was analysed according to Joos-
ten et al. (2011) and Kabsch and Sander (1983). The aver-
age aurein conformation was calculated over the last 50 
ns of simulation since fewer conformational changes on 
the secondary structure were obseved. Aureins in a water 
environment exhibited an unstable secondary structure. 
However, for the non-amidated peptides the percentage 
of α-helix or β-sheet was maintained (see Table 2). In the 
presence of TFE the aureins displayed a stable α-helical 
conformation, which was slightly affected by the terminal 
section (see Table 2). Aureins 2.6 and 3.1 showed a differ-
ent α-helical conformation in the presence of TFE due to 
the difference in the number of amino acids (16 for aurein 
2.6 and 17 for aurein 3.1) and in the sequence of the amino 
acids in the peptide. Aurein 2.6 has a stable α-helical core 
fomed by ALA6-LYS7-LYS8, which is more stable than 
the core formed by aurein 3.1 (VAL6-LYS7-LYS8), which 
has a mutation of the amino acid ALA6 with VAL6. In 
both DMPC and DMPS membranes aurein 2.6-CONH2 
displayed a stable α-helical conformation (31 and 32 % 
respectively). In DMPC the aureins also exhibited a stable 
β-sheet structure (12 %). Aurein 2.6-COOH exhibited a 
lower percentage of β-sheet structure compared to the ami-
dated peptide isoforms (28 % in DMPC and DMPS). The 
α-helical conformation of aurein 3.1-CONH2 is more sta-
ble in the presence of DMPS (24 %) than DMPC (16 %), 
whilst in the case of aurein 3.1-COOH the α-helical con-
formation is more stable in the presence of DMPC (30 % 
against 12 %). For all aurein 3.1 isoforms a stable β-sheet 
conformation is also observed. In general peptides located 
in the membrane exhibited a greater percentage of α-helical 
structure compared to peptides on the surface of the lipid 
bilayer. The highest percentage (82 %) of helical structure 
was observed for aurein 3.1-COOH inside the DMPC lipid 
bilayer (Table 2). In TFE the percentage helicity obtained 
computationally and experimentally showed a similar 
trend; however in the presence of lipid there were some dif-
ferences in the values obtained.
Dynamics properties of aureins in the presence of the 
lipid bilayer using MD.
Role of the C‑terminus in the peptide/lipid bilayer 
interaction
In both peptides the presence of NH2 at the C-terminus ena-
bles deeper penetration with the head groups of the DMPC 
lipid bilayer (Fig. 2). Here, the insertion of the N- (in red 
in Fig. 2) and C-terminus (in blue in Fig. 2) of the peptide 
is observed. In the case of non-amidated aureins the pep-
tides interact with the lipid bilayer through the N-terminal 
(in red in Fig. 2) residues favouring a tilted insertion (see 
supplementary information). Moreover, insertion of aurein 
peptide into the DMPS bilayer is observed in compari-
son to a DMPC bilayer. In contrast, a different behaviour 
is observed in the case of amidation on the C-terminus. 
Here, the NH2 group interacts with the head group of the 
DMPS lipid bilayer enhancing the interaction of the N- and 
C-terminus of the peptide with DMPS (see Fig. 2). The 
non-amidated aureins are situated in the water-lipid inter-
face region with the N-terminus and interact with the head 
groups of the lipid bilayer. Different residues in the ami-
dated aureins are involved in the interaction with the lipid 
bilayer, influencing the mechanism of penetration. The 
NH2 at the C-terminus is influenced by the presence of PO4 
groups in DMPC and CO2 in the DMPS lipid bilayer. In 
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the second set of simulations the three peptides are inside 
the lipid bilayer. Inside the DMPC and DMPS bilayer the 
presence of NH2 at the C-terminus highlights that each sin-
gle peptide interacts with the head groups of the DMPC 
lipid bilayer (Fig. 3). In contrast, in the case of aurein 2.6-
COOH, the C-terminus interacts with the inner part of the 
head groups of the DMPC lipid bilayer showing increased 
mobility of the peptides inside the hydrophobic core of 
the phospholipid bilayer (Fig. 3). The peptides after 200 
ns show a very stable secondary structure inside the lipid 
bilayer. 
Hydrogen bonds
Hydrogen bond (HB) analysis was performed for inter-
actions between the peptide, N-terminus, or peptide 
Fig. 2  Snapshot, after 200 ns, 
of three aureins 2.6 and 3.1 
starting outside the DMPC and 
DMPS membrane. The N-ter-
minus (in red) and C-terminus 
(in blue) are highlighted in the 
graphic. The right‑hand graph‑
ics in each panel show the par-
tial densities of the components 
calculated in the last 50 ns of 
simulation: overall lipid density 
(solid black line), lipid head 
groups (dots), lipid tail groups 
(dashed line), phosphate atoms 
(brown line), the three peptides 
(blue line), peptide A (red line), 
peptide B (green line), and 
peptide C (orange line)
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C-terminus (for the aureins outside the membrane) and the 
head groups of the membrane as a function of the simu-
lation time. The number of HBs between the peptide and 
lipid bilayer increases with time as the peptide interacts 
more deeply with the lipid bilayer (Fig. 4). In the major-
ity of cases after 50 ns circa 10 HBs are observed between 
the peptides and lipid bilayer. The number of HBs between 
the C- and N-terminus and lipid bilayer depends on the 
presence of the NH2 group on the C-terminus. For car-
boxylate peptides the number of HBs between the terminus 
and lipid bilayer is strongly influenced by the lipid bilayer 
and bonding properties of the peptide sequence. Circa 2.5 
HBs between the N-terminus and lipid bilayer are observed 
for aurein 2.6-COOH in DMPC. The HBs between the 
C-terminus and lipid bilayer are observed after 40 ns (2 
HBs) (Fig. 4). Circa 1 HB between the C-terminus and 
lipid bilayer is observed for aurein 2.6-COOH in DMPS. In 
contrast, HBs between the N-terminus and lipid bilayer are 
observed only at the beginning of the simulations (0–10 ns) 
and are very unstable. Circa 3 HBs between the N-termi-
nus and lipid bilayer are observed for aurein 3.1-COOH in 
DMPC. The HBs between the C-terminus and lipid bilayer 
are observed after 140 ns (2 HBs) (Fig. 4). Aurein 3.1-
COOH in DMPS shows a different trend compared to the 
previous peptides; circa 2 HBs between the N-terminus and 
lipid bilayer are observed during the simulations. While the 
HBs between the C-terminus and lipid bilayer are unsta-
ble with a relatively short-lived formation, circa 3 HBs 
Fig. 3  Snapshot, after 200 
ns, of three aureins 2.6 (A 
2.6) and 3.1 (A 3.1) starting 
inside the DMPC and DMPS 
membrane. The N-terminus (in 
red) and C-terminus (in blue) 
are highlighted in the graphic. 
The right‑hand graphics in each 
panel show partial densities 
of the components calculated 
in the last 50 ns of simulation: 
overall lipid density (solid black 
line), lipid head groups (dots), 
lipid tail groups (dashed line), 
phosphate atoms (brown line), 
the three peptides (blue line), 
peptide A (red line), peptide 
B (green line), and peptide C 
(orange line)
Eur Biophys J 
1 3
between the C-terminus and lipid bilayer are observed after 
20 ns for aurein 2.6-CONH2 in DMPC, while there are no 
HBs between the N-terminus and lipid bilayer. Aurein 2.6-
CONH2 in DMPS has an increased number of HBs (circa 
3) between the C-terminus and lipid bilayer compared to 
aurein 2.6-COOH. HBs between the N-terminus and lipid 
bilayer are also more stable during the simulation time 
(circa 2.5 HBs) (Fig. 4). Circa two HBs between the N-ter-
minus and lipid bilayer are observed up to 70 ns aurein 3.1-
CONH2 in DMPC. The HBs between the C-terminus and 
lipid bilayer are observed after 95 ns (circa 2 HBs). Circa 3 
HBs between the N-terminus and lipid bilayer are observed 
during the simulations for aurein 3.1-CONH2 in DMPS. 
While the HBs between the C-terminus and lipid bilayer 
(circa 2) are observed after 100 ns, there is no significant 
difference in the formation of HBs between the peptides 
and lipid bilayer. The presence of NH2 at the terminus of 
the peptide showed a larger number of HBs between the 
peptide C-terminus and lipid bilayer (red line in Fig. 4).
Discussion
A wide range of structural conformations has been dis-
played by AMPs (Maget-Dana 1999) and the ability of an 
AMP to interact with a target membrane not only depends 
upon the peptide structural characteristics but also the 
membrane target (Nguyen et al. 2011). The mechanism of 
AMP interaction is dependent on the membrane environ-
ment and currently no single model can explain the mecha-
nism of action. However, it is generally accepted that the 
targeting and binding of the peptide to the membrane are 
via electrostatic interactions between the cationic regions 
of the peptide and negatively charged moieties occur-
ring in membranes of these target cells (Dennison et al. 
2007). Once associated with the membrane, one factor that 
has been identified as important for activity is the stabil-
ity of the secondary structure prior to membrane penetra-
tion (Giangaspero et al. 2001; Dennison et al. 2012b, a). 
Cabrera et al. stated that C-terminal amidation is important 
for both the helix stability and lytic activity of peptides 
(dos Santos Cabrera et al. 2004). CD and MD structural 
studies indicated that both aurein isoforms were unstruc-
tured in solution (Fig. 1; Table 2) and then fold to form an 
α-helical conformation in the presence of a lipid interface 
(Dennison et al. 2013).
Many studies have shown that the antimicrobial activ-
ity of AMPs is related to the positive charge of peptides 
(Giangaspero et al. 2001; Dennison et al. 2009b, 2003, 
2005; Benko-Iseppon et al. 2010). Amidated peptides 
have a higher positive charge than the corresponding non-
amidated peptide, which may be the reason why some are 
more active. The greater net charge on aurein 2.6-CONH2 
and aurein 3.1-CONH2 compared to aurein 2.6-COOH and 
aurein 3.1-COOH would therefore be predicted to enhance 
the membrane association. To obtain further information on 
the mode of action of aurein 2.6 and aurein 3.1 analogues, 
CD experiments were performed in the presence of TFE. 
Aurein 2.6-CONH2 and aurein 3.1-CONH2 were seen to 
adopt the α-helical structure in the presence of TFE [71 
and 61 % α-helix respectively (Table 2)] and show a greater 
helicity percentage compared to the carboxyl-free C-termi-
nus. The same behaviour has been confirmed by MD simu-
lations, which showed that the peptides exhibited a stable 
conformation (Table 2). In the presence of lipids CD analy-
sis showed that the aurein 2.6-CONH2 possesses a greater 
helicity compared to aurein 2.6-COOH supported by MD 
analysis. Furthermore, in DMPC, the aurein 2.6 can bind 
the stabilising helix at the membrane interface (Table 2), 
which leads to different modes of interaction and mem-
brane binding compared to aurein 3.1.
Peptide binding and partitioning into a membrane are 
affected by the ability of an AMP to alter the lipid poly-
morphism of a membrane (Epand 1997). A number of fac-
tors determine the lipid polymorphism of a membrane, for 
example the location of the peptide in a membrane, the 
presence of amino acids, which contain several C-C bonds 
in the side chain such as LYS, and physiochemical charac-
teristics such as charge and amphiphilicity, with evidence 
to show that hydrophobicity determines the level of mem-
brane partitioning. The MD analysis in Fig. 2 shows that 
for aurein 2.6-COOH and aurein 3.1-COOH in the pres-
ence of a DMPC and DMPS bilayer, the peptides orientate 
horizontally to the water-lipid interface, allowing shallow 
penetration into the hydrophobic core of the lipid interior. 
Here the LYS amino acids, which are centrally located in 
the peptide, are interacting with the head groups of the lipid 
bilayer forming HBs with the lipid bilayer. This horizontal 
orientation of the peptide would lead to lipid head groups 
being pushed aside by the peptide and hence forcing a gap 
in the membrane hydrophobic region. This result is com-
parable to other AMPs, which may utilise a carpet or toroi-
dal pore-type mechanism (Sato and Feix 2006; Hoskin and 
Ramamoorthy 2008; Fernandez et al. 2012). The amidated 
C-terminus of the peptide can also form a larger number 
of HBs in comparison with carboxyl peptides in all cases. 
This affects the secondary structures and activities of the 
amidated and non-amidated aurein 2.6 and aurein 3.1 at the 
water-lipid interface.
The amidated peptides tilt their helices (Fig. 2) and 
hence the lipids distort their acyl chains by compressing 
the lipids to match the peptide molecular architecture or 
by stretching of the acyl chains (Ramadurai et al. 2010). 
Ramadurai et al. showed that the degree of the tilt is due 
to positive and negative mismatch due to the presence of 
snorkelling Lys residues. In turn this leads to a curvature 
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around the peptide in the bilayer leading to membrane 
destabilisation (Ramadurai et al. 2010). This oblique ori-
entation mechanism has been proposed for other aurein 
amidated peptides, such as aurein 1.2 (Marcotte et al. 2003) 
and aurein 2.3 (Mura et al. 2013), which have been shown 
to insert into the membrane with a shallow angle between 
30◦ and 60◦ leading to membrane destabilisation.
In conclusion, our analysis highlights how the mecha-
nism of interaction between the peptide and lipid bilayer is 
dependent on whether the peptide is amidated at the C-ter-
minus. The configuration of the peptide inside the lipid 
bilayer also throws light on the interaction between the 
peptide and bilayer component. When the peptides and the 
lipid bilayer are in close contact, HBs are formed between 
the carboxyl terminal and head groups of lipid molecules, 
which contribute to the different behaviour of peptides at 
the water-lipid interface.
Aurein 2.6-CONH2 shows a contribution of α-helical 
conformation larger than aurein 2.6-COOH in both the 
membranes while aurein 3.1-CONH2 shows a larger α
-helical conformation only in the presence of the DMPC 
membrane. These results are in agreement with CD experi-
ments. When the peptides are inside the membrane, the 
LYS interacts with the head group of the lipid bilayer, 
staying anchored to the hydrophilic interface region 
(Fig. 5). This behaviour of the LYS residue creates a per-
turbation on the membrane allowing the penetration of 
water molecules.
Fig. 5  Bottom Interaction of 
the lysine residue (in blue) of 
aurein 2.6 with the phosphate 
atoms (brown) of the DMPC 
lipid bilayer at 200 ns. Top 
Magnified image of one α-heli-
cal structure
Fig. 4  The hydrogen bond number vs. time for three aureins 2.6 
and aureins 3.1 (when the peptides are starting from the configura-
tion outside the lipid bilayer), between peptides and lipid molecules 
(P–L), between C-terminal groups of the peptide (COOH or CONH2
) and lipid bilayer (C-term-L), and between the N-terminal groups of 
the peptide and lipid bilayer (N-term-L)
◂
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